Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 EUR | -0.37% | +3.45% | +12.50% |
Apr. 05 | Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors | CI |
Mar. 22 | Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition | MT |
Sales 2023 | 3.91M 4.21M | Sales 2024 * | 5.7M 6.15M | Capitalization | 55.11M 59.43M |
---|---|---|---|---|---|
Net income 2023 | -3M -3.24M | Net income 2024 * | -3M -3.24M | EV / Sales 2023 | 14.1 x |
Net cash position 2023 * | 5.8M 6.25M | Net cash position 2024 * | 2.6M 2.8M | EV / Sales 2024 * | 9.21 x |
P/E ratio 2023 |
-14.3
x | P/E ratio 2024 * |
-16.9
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 64.06% |
1 day | -0.37% | ||
1 week | +3.45% | ||
Current month | +4.25% | ||
1 month | -5.92% | ||
3 months | +18.42% | ||
6 months | +16.38% | ||
Current year | +12.50% |
Managers | Title | Age | Since |
---|---|---|---|
Timo Lehtonen
CEO | Chief Executive Officer | 49 | 19-02-28 |
Director of Finance/CFO | 57 | 21-01-31 | |
Chairman | 53 | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 53 | 16-04-30 | |
Director/Board Member | 50 | 19-12-31 | |
Director/Board Member | 65 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.7 | -0.37% | 5 557 |
24-05-08 | 2.71 | 0.00% | 28,734 |
24-05-07 | 2.71 | -0.37% | 13,584 |
24-05-06 | 2.72 | +4.21% | 74,579 |
24-05-03 | 2.61 | +1.95% | 33,510 |
Delayed Quote Nasdaq Helsinki, May 10, 2024 at 05:10 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.50% | 59.38M | |
+73.46% | 12.41B | |
-16.75% | 8.12B | |
+5.93% | 6.59B | |
-3.88% | 5.83B | |
+13.79% | 5.46B | |
+40.99% | 5.05B | |
-19.05% | 4.02B | |
-34.55% | 2.47B | |
-0.50% | 2.02B |
- Stock Market
- Equities
- BRETEC Stock